A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/7072 (2006.01) A61P 25/16 (2006.01)
Patent
CA 2566612
The present invention provides methods for increasing secretion of dopamine and other neurotransmitters and treating or reducing the incidence of diseases involving decreased secretion of dopamine and other neurotransmitters, e.g. Parkinson's disease, comprising administering to the subject a uridine or a source thereof, and compositions for treating or reducing an incidence of Parkinson's disease, comprising a uridine, a uridine monophosphate, or a source thereof.
L'invention concerne des procédés permettant d'augmenter la sécrétion de la dopamine et d'autres neurotransmetteurs et de traiter ou réduire l'incidence de maladies impliquant une baisse de la sécrétion de la dopamine et d'autres neurotransmetteurs, par exemple la maladie de Parkinson, qui consistent à administrer au patient une uridine ou une source de celle-ci, ainsi que des compositions permettant de traiter ou de réduire l'incidence de la maladie de Parkinson, qui renferment une uridine, un monophosphate d'uridine, ou une source de ceux-ci.
Gowling Lafleur Henderson Llp
Massachusetts Institute Of Technology
LandOfFree
Uridine effects on dopamine release does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Uridine effects on dopamine release, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uridine effects on dopamine release will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1818661